Literature DB >> 3917280

Lymphokine-mediated induction of cytolytic activity in a T cell hybridoma.

O Kanagawa, J M Chiller.   

Abstract

Functionally inducible CTL hybridomas were constructed by fusing alloantigen-specific T cells (C57BL/6 alpha-DBA/2) with cells from the rat thymoma line W/FU (C58NT)D. A cloned hybridoma line (KSH.4.13.6) that was specifically cytolytic in the presence of activated rat spleen cell supernatant fluid (rat Con A SN) lost activity when transferred to normal medium. However, a cytolytic activity could be reinduced by culturing KSH.4.13.6 cells in medium containing rat Con A SN or secondary mixed leukocyte culture SN. By using various sources of SN, it was found that cytolytic induction required two different factors. PMA-induced EL-4 SN and SN from antigen-activated cloned T cells, neither of which were capable of inducing cytolytic activity alone, were able to synergize in the cytolytic induction of KSH.4.13.6 IFN-gamma and IL 1 failed to induce cytolytic activity even in the presence of EL-4 SN. Furthermore, this hybridoma produced macrophage activating factor (MAF) upon culture in rat Con A SN, although MAF production could not be induced by either specific antigen or lectins. The kinetics of induction and loss of cytolytic activity mediated by rat Con A SN were similar to those of the induction of MAF production. However, EL-4 SN, which by itself was incapable of inducing cytolytic activity, was able to induce MAF production in the KSH.4.13.6 hybrid to an extent similar to that induced by rat Con A SN. These results suggest that the induction of cytolytic activity and of MAF production in this cloned hybridoma cell line are regulated by different mechanisms. Such a functionally inducible T cell hybrid may provide a tool for biochemical and molecular analysis of T cell function and regulation, and of the characterization of cytokines required for CTL differentiation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3917280

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Inducible functions in hybrids of a Lyt-2+ BW5147 transfectant and the 2C CTL line.

Authors:  J J Gu; P D Gottlieb
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

2.  Differential susceptibility of mouse Lyt-2 and Lyt-3 genes to negative regulation.

Authors:  I Hwang; J J Gu; P D Gottlieb
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

3.  Study of idiotypes expressed by monoclonal antibodies to the 35 kD and 12 kD antigens of Mycobacterium leprae.

Authors:  K Praputpittaya; J Ivanyi
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

4.  Hybrid hybridoma producing a bispecific monoclonal antibody that can focus effector T-cell activity.

Authors:  U D Staerz; M J Bevan
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

5.  The MHC molecule I-E is necessary but not sufficient for the clonal deletion of V beta 11-bearing T cells.

Authors:  J Bill; O Kanagawa; D L Woodland; E Palmer
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

6.  Inhibition of MHC class II-restricted T cell response by Lyt-2 alloantigen.

Authors:  O Kanagawa; R Maki
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

7.  Enhancement of therapeutic effect of interleukin-2 on spontaneous pulmonary metastases of Lewis lung carcinoma by killer helper factor associated with increased induction of killer activity.

Authors:  K Fukuta; S Sone; M Kitahara; M Okada; T Ogura
Journal:  Jpn J Cancer Res       Date:  1989-06

8.  Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha.

Authors:  G E Ranges; I S Figari; T Espevik; M A Palladino
Journal:  J Exp Med       Date:  1987-10-01       Impact factor: 14.307

9.  CD4 rat x rat and mouse x rat T cell hybridomas produced by fusion of established T cell lines and clones to W/Fu (C58NT)D.

Authors:  A M Boots; M J van Lierop; M H Wauben; P J van Kooten; E J Hensen; W van Eden
Journal:  J Immunol Methods       Date:  1991-11-05       Impact factor: 2.303

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.